NARANSIN, predominantly represented by narasin A, is a polyether monocarboxylic acid ionophore antibiotic produced by fermentation of Streptomyces aureofaciens. Acting through the reversible complexation… Read more
NARANSIN, predominantly represented by narasin A, is a polyether monocarboxylic acid ionophore antibiotic produced by fermentation of Streptomyces aureofaciens. Acting through the reversible complexation and transmembrane transport of monovalent cations, it disrupts osmotic gradients and metabolic equilibrium in target cells. It is widely administered in veterinary medicine as a feed additive to prevent coccidiosis in poultry and livestock and to manage infections caused by susceptible Gram-positive pathogens, notably Clostridium perfringens. Analytical laboratories utilize reference standards, synthetic impurities, degradation products, and stable isotope labelled analogues of narasin for method development, regulatory compliance, and routine quality control. These reference materials are critical for chromatographic quantification, impurity profiling, and residue monitoring in pharmaceutical formulations, premixes, and animal feed substrates using high-performance liquid chromatography and tandem mass spectrometry.